174 related articles for article (PubMed ID: 37744381)
1. Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models.
Abboud R; Kim S; Staser K; Jayasinghe RG; Lim S; Amatya P; Frye CC; Kopecky B; Ritchey J; Gao F; Lavine K; Kreisel D; DiPersio JF; Choi J
Front Immunol; 2023; 14():1264496. PubMed ID: 37744381
[TBL] [Abstract][Full Text] [Related]
2. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
[TBL] [Abstract][Full Text] [Related]
3. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine with cyclosporine or with tacrolimus exerts a synergistic effect and induces tolerance in the rat.
Jeske HC; Oberladstätter J; Schneeberger S; Hittmair A; Klima G; Obrist P; Ollinger R; Roberts K; Schubert H; Steurer W; Margreiter R
Transplantation; 2003 Oct; 76(7):1046-52. PubMed ID: 14557751
[TBL] [Abstract][Full Text] [Related]
5. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
[TBL] [Abstract][Full Text] [Related]
6. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide attenuated the rejection of major histocompatibility complex fully-mismatched cardiac allografts in mice.
Yan S; Zhang QY; Zhou B; Xue L; Chen H; Wang Y; Zheng SS
Transplant Proc; 2009 Jun; 41(5):1855-8. PubMed ID: 19545743
[TBL] [Abstract][Full Text] [Related]
8. Tolerance of T-independent xeno-antibody responses in the hamster-to-rat xenotransplantation model is species-restricted but not tissue-specific.
Chong AS; Ma LL; Yin D; Blinder L; Shen J; Williams JW
Xenotransplantation; 2000 Feb; 7(1):48-57. PubMed ID: 10809057
[TBL] [Abstract][Full Text] [Related]
9. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Li J; Xia J; Zhang K; Xu L
J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group.
Kahan BD; Julian BA; Pescovitz MD; Vanrenterghem Y; Neylan J
Transplantation; 1999 Nov; 68(10):1526-32. PubMed ID: 10589950
[TBL] [Abstract][Full Text] [Related]
11. Consecutive low doses of cyclosporine A induce pro-inflammatory cytokines and accelerate allograft skin rejection.
López-Flores R; Bojalil R; Benítez JC; Ledesma-Soto Y; Terrazas CA; Rodríguez-Sosa M; Terrazas LI
Molecules; 2011 May; 16(5):3969-84. PubMed ID: 21562466
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
[TBL] [Abstract][Full Text] [Related]
13. Brief cyclosporine treatment prevents intrathymic (IT) tolerance induction and precipitates acute rejection in an IT rat cardiac allograft model.
Smith CR; Mohanakumar T; Shimizu Y; Yu S; Otomo N; Kaleem Z; Flye MW
Transplantation; 2000 Jan; 69(2):294-9. PubMed ID: 10670641
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
[TBL] [Abstract][Full Text] [Related]
15. Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts.
Yamada Y; Sekine Y; Yoshida S; Yasufuku K; Petrache I; Benson HL; Brand DD; Yoshino I; Wilkes DS
J Immunol; 2009 Jul; 183(1):237-45. PubMed ID: 19542435
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine A Inhibits the T-bet-Dependent Antitumor Response of CD8(+) T Cells.
Rovira J; Renner P; Sabet-Baktach M; Eggenhofer E; Koehl GE; Lantow M; Lang SA; Schlitt HJ; Campistol JM; Geissler EK; Kroemer A
Am J Transplant; 2016 Apr; 16(4):1139-47. PubMed ID: 26855194
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory functions of low-molecular weight hyaluronate in an acute rat renal allograft rejection model.
Knoflach A; Azuma H; Magee C; Denton M; Murphy B; Iyengar A; Buelow R; Sayegh MH
J Am Soc Nephrol; 1999 May; 10(5):1059-66. PubMed ID: 10232693
[TBL] [Abstract][Full Text] [Related]
18. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.
MacDonald AS;
Transplantation; 2001 Jan; 71(2):271-80. PubMed ID: 11213073
[TBL] [Abstract][Full Text] [Related]
19. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat.
Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165
[TBL] [Abstract][Full Text] [Related]
20. A ruthenium (III) polyaminocarboxylate complex, a novel nitric oxide scavenger, enhances graft survival and decreases nitrosylated heme protein in models of acute and delayed cardiac transplant rejection.
Pieper GM; Roza AM; Adams MB; Hilton G; Johnson M; Felix CC; Kampalath B; Darkes M; Wanggui Y; Cameron B; Fricker SP
J Cardiovasc Pharmacol; 2002 Mar; 39(3):441-8. PubMed ID: 11862124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
